Citadel Advisors’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $187K | Buy |
|
|||||
|
2023
Q4 | $181K | Sell |
|
|||||
|
2023
Q3 | $501K | Buy |
|
|||||
|
2023
Q2 | $424K | Sell |
|
|||||
|
2023
Q1 | $458K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $652K | Sell |
|
|||||
|
2022
Q2 | $943K | Buy |
|
|||||
|
2022
Q1 | $252K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $256K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $254K | Buy |
|
|||||
|
2020
Q2 | $259K | Sell |
|
|||||
|
2020
Q1 | $769K | Sell |
|
|||||
|
2019
Q4 | $1.14M | Buy |
|
|||||
|
2019
Q3 | $1.54M | Buy |
|
|||||
|
2019
Q2 | $807K | Sell |
|
|||||
|
2019
Q1 | $836K | Sell |
|
|||||
|
2018
Q4 | $1.24M | Buy |
|
|||||
|
2018
Q3 | $526K | Buy |
|
|||||
|
2018
Q2 | $488K | Buy |
|
|||||
|
2018
Q1 | $362K | Buy |
|
|||||
|
2017
Q4 | $287K | Buy |
|
|||||
|
2017
Q3 | $252K | Buy |
|
|||||
|
2017
Q2 | $205K | Sell |
|
|||||
|
2017
Q1 | $559K | Buy |
|
|||||
|
2016
Q4 | $233K | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2.31M | Buy |
|
|||||
|
2015
Q3 | $3.03M | Buy |
|
|||||
|
2015
Q2 | $399K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $195K | Buy |
|